10.1. Analysis.
Comparison 10 Hydroxyzine 75 mg/d versus placebo, Outcome 1 Primary outcome 1. Patient‐assessed symptoms: global evaluation of the antipruritic effect of treatment: number of participants who reported a marked or complete response.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.